JPH0635467B2 - Novel glycosylation method - Google Patents
Novel glycosylation methodInfo
- Publication number
- JPH0635467B2 JPH0635467B2 JP2062066A JP6206690A JPH0635467B2 JP H0635467 B2 JPH0635467 B2 JP H0635467B2 JP 2062066 A JP2062066 A JP 2062066A JP 6206690 A JP6206690 A JP 6206690A JP H0635467 B2 JPH0635467 B2 JP H0635467B2
- Authority
- JP
- Japan
- Prior art keywords
- benzyl
- tetra
- reaction
- hexane
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000006206 glycosylation reaction Methods 0.000 title claims description 9
- 230000013595 glycosylation Effects 0.000 title claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 10
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- -1 pyranosyl bromide Chemical compound 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000004809 Teflon Substances 0.000 description 8
- 229920006362 Teflon® Polymers 0.000 description 8
- 239000002808 molecular sieve Substances 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- WXYNLXPSTFTJJC-RUOAZZEASA-N (2r,3r,4s,5r,6r)-2-bromo-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxane Chemical compound C([C@H]1O[C@@H]([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)Br)OCC1=CC=CC=C1 WXYNLXPSTFTJJC-RUOAZZEASA-N 0.000 description 6
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- XDIPNAGULDXWAU-YGMGGQQPSA-N (3R,4S,5R,6R)-2-[(2-methylpropan-2-yl)oxy]-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxane Chemical compound C(C1=CC=CC=C1)O[C@H]1C(OC(C)(C)C)O[C@@H]([C@H]([C@@H]1OCC1=CC=CC=C1)OCC1=CC=CC=C1)COCC1=CC=CC=C1 XDIPNAGULDXWAU-YGMGGQQPSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000006945 Knorr synthesis reaction Methods 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- NPOKZMNZAPKSBT-IOVATXLUSA-N (3r,4s,5r)-2-bromooxane-3,4,5-triol Chemical class O[C@@H]1COC(Br)[C@H](O)[C@H]1O NPOKZMNZAPKSBT-IOVATXLUSA-N 0.000 description 1
- BDJLMNAHVITKNE-GASJEMHNSA-N (3r,4s,5s,6r)-2-bromo-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC[C@H]1OC(Br)[C@H](O)[C@@H](O)[C@@H]1O BDJLMNAHVITKNE-GASJEMHNSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-Me3C6H3 Natural products CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- UWKQJZCTQGMHKD-UHFFFAOYSA-N 2,6-di-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=N1 UWKQJZCTQGMHKD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- FEQXFAYSNRWXDW-RKQHYHRCSA-N [(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(hydroxymethyl)oxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1O[C@H](CO)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O FEQXFAYSNRWXDW-RKQHYHRCSA-N 0.000 description 1
- MOKYEUQDXDKNDX-DFLSAPQXSA-N [(2r,3r,4s,5r,6s)-6-methoxy-3,4,5-tris(phenylmethoxy)oxan-2-yl]methanol Chemical compound O([C@@H]1[C@@H](CO)O[C@@H]([C@@H]([C@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OC)CC1=CC=CC=C1 MOKYEUQDXDKNDX-DFLSAPQXSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002340 glycosyl compounds Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- CINAUOAOVQPWIB-JTQLQIEISA-N methyl (2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoate Chemical compound COC(=O)[C@H](CO)NC(=O)OCC1=CC=CC=C1 CINAUOAOVQPWIB-JTQLQIEISA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は糖アノマーの新規なグリコシル化方法に関す
る。TECHNICAL FIELD The present invention relates to a novel glycosylation method of a sugar anomer.
[従来技術] グリコシル化法は糖アノマーの水酸基をハロゲン化した
ハロゲン化糖を銀塩あるいは水銀塩の存在下、他のアル
コール類とカップリングさせるいわゆるKoenig−
Knorr反応を利用する方法が主であった。[Prior Art] The glycosylation method is a so-called Koenig- coupling of a halogenated sugar obtained by halogenating a hydroxyl group of a sugar anomer with another alcohol in the presence of a silver salt or a mercury salt.
The method utilizing the Knorr reaction has been the main method.
また、トリエチルアミンの存在下、メタノールのピラノ
シルブロミドによるグリコシル化法が知られているが、
より複雑なアルコール類を受容体とする反応では、収率
が非常に低い結果が得られている[C.Schuerc
h等“Carbohydr.Res.”第39巻第33
頁(1975年)]。In addition, a glycosylation method using pyranosyl bromide of methanol in the presence of triethylamine is known.
Very low yields have been obtained in reactions involving more complex alcohols as acceptors [C. Schuerc
h et al. "Carbohydr. Res." Vol. 39, No. 33
Page (1975)].
[発明が解決しようとする問題点] Koenig−Knorr反応に代表される従来のグリ
コシル化方法を利用する場合、活性化剤として過剰の銀
あるいは水銀のような重金属塩を使うため経済的でない
という点に問題点があった。[Problems to be Solved by the Invention] When a conventional glycosylation method represented by the Koenig-Knorr reaction is used, it is uneconomical to use an excessive heavy metal salt such as silver or mercury as an activator. There was a problem.
また、前述のScheurchらの方法では、重金属塩
を使わないという点では優れた方法であるが、メタノー
ルのような低級アルコール以外の基質には適用できな
い。Further, the above-mentioned method of Scheurch et al. Is an excellent method in that heavy metal salts are not used, but it cannot be applied to substrates other than lower alcohols such as methanol.
[問題点を解決するための手段] 本発明者らは、アルコール類のグリコシル化法に関して
鋭意研究を行なった結果、高圧条件下において種々の水
酸基を有する受容体をグリコシル化を可能にするような
新規グリコシル化反応を見いだし、本発明を完成した。[Means for Solving Problems] As a result of intensive studies on the glycosylation method of alcohols, the present inventors have found that receptors having various hydroxyl groups can be glycosylated under high pressure conditions. A new glycosylation reaction was found and the present invention was completed.
本発明のハロゲン化糖誘導体としては、例えばグルコピ
ラノシルブロミド、ガラクトピラノシルブロミド、マン
ノピラノシルブロミド等の通常のヘキソースのピラノシ
ルブロミド、キシロピラノシルブロミドあるいはアラビ
ノピラノシルブロミド等の通常のペントースのピラノシ
ルブロミド、これらの糖のデオキシあるいはアミノデオ
キシ誘導体などである。なお、これらのハロゲン化糖の
水酸基またはアミノ基は保護基で保護しておく。ハロゲ
ン化糖は、アルコール類に対して1.2〜1.5当量の
範囲で使用する。The halogenated sugar derivative of the present invention includes, for example, glucopyranosyl bromide, galactopyranosyl bromide, mannopyranosyl bromide, and other common hexose pyranosyl bromides, xylopyranosyl bromides, and arabinopyranos. Examples include usual pentose pyranosyl bromides such as silbromide, and deoxy or aminodeoxy derivatives of these sugars. The hydroxyl group or amino group of these halogenated sugars is protected with a protective group. The halogenated sugar is used in the range of 1.2 to 1.5 equivalents with respect to the alcohol.
本発明の受容体化合物であるアルコール類としては、例
えばメタノール、エタノール、シクロヘキサノール、t
ert−ブチルアルコール等のアルコール類、ガラクト
ース、グリコース、マンノース等の単糖類、コレステロ
ール等のステロール類、セリン、トレオニン等のアミノ
酸類などがあげられる。Examples of alcohols which are the acceptor compounds of the present invention include methanol, ethanol, cyclohexanol, t
Examples thereof include alcohols such as ert-butyl alcohol, monosaccharides such as galactose, glucose, mannose, sterols such as cholesterol, and amino acids such as serine and threonine.
即ち、一般式R−0Hで表されるような水酸基を有する
種々の化合物が受容体となりうる。なお、これらの受容
体化合物に他の官能基がある場合、これらは保護基によ
り保護しておく。That is, various compounds having a hydroxyl group represented by the general formula R-0H can serve as acceptors. In addition, when these acceptor compounds have other functional groups, these are protected by a protecting group.
本発明で使用する三級アミン類としては、トリエチルア
ミン、トリブチルアミン、ジイソプロピルエチルアミ
ン、2,6−ルチジン、2,6−ジ−tert−ブチル
ピリジン、2,4,6−コリジンあるいはテトラメチル
尿素などがあげられる。三級アミン類は、アルコール類
に対して1.2〜3.0当量、好ましくは1.2〜1.
5当量の範囲で使用する。Examples of the tertiary amines used in the present invention include triethylamine, tributylamine, diisopropylethylamine, 2,6-lutidine, 2,6-di-tert-butylpyridine, 2,4,6-collidine and tetramethylurea. can give. The tertiary amines are 1.2 to 3.0 equivalents, preferably 1.2 to 1.
Use in the range of 5 equivalents.
本発明グリコシル化は、ハロゲン化糖、アルコール類、
上記の三級アミン類及びモレキュラシーブ4Aを溶媒に
溶かし、テフロン製のカプセルに封じ込み、高圧反応容
器にセットし、カプセルに圧力をかけて反応させる。溶
媒としては、塩化メチレン、1,2−ジクロロエタン等
のハロゲン化炭化水素類、ジエチルエーテル、テトラヒ
ドロフラン、1,2−ジメトキシエタン等のエーテル
類、トルエン等の芳香族炭化水素類、アセトニトリル類
などがあげられる。The glycosylations of the present invention include halogenated sugars, alcohols,
The above-mentioned tertiary amines and molecular sieve 4A are dissolved in a solvent, sealed in a Teflon capsule, set in a high-pressure reaction vessel, and pressure is applied to the capsule to react. Examples of the solvent include halogenated hydrocarbons such as methylene chloride and 1,2-dichloroethane, ethers such as diethyl ether, tetrahydrofuran and 1,2-dimethoxyethane, aromatic hydrocarbons such as toluene, acetonitriles and the like. To be
反応圧力については、4000〜15000気圧の範囲
で設定できるが、8000〜15000気圧の範囲が望
ましい。反応温度については、室温から100℃の範囲
で目的物に応じて設定できるが、室温から40℃が適当
である。反応時間は受容体の反応性、反応温度により左
右され一定しないが、通常は、20〜40時間程度で充
分である。The reaction pressure can be set in the range of 4000 to 15000 atm, but is preferably in the range of 8000 to 15000 atm. The reaction temperature can be set in the range of room temperature to 100 ° C. according to the intended product, but room temperature to 40 ° C. is suitable. The reaction time is not constant depending on the reactivity of the receptor and the reaction temperature, but 20 to 40 hours is usually sufficient.
本発明において得られた化合物は、シリカゲルカラムク
ロマトグラフィー、再結晶などの通常の手段により精製
することができる。The compound obtained in the present invention can be purified by a usual means such as silica gel column chromatography and recrystallization.
[発明の効果] 本発明の方法に従い、高圧条件下、ハロゲン化糖誘導体
とアルコール類から、対応するグリコシル化合物が得ら
れる。本発明の方法は操作が簡便であり、銀あるいは水
銀などの重金属塩を一切用いる必要がない点で従来の方
法に比較して、安全で経済的方法である。また、後述す
る実施例に示すとおり、本発明の方法に従えば、α−O
−グリコシド結合を高い選択性で得ることができる。[Effect of the Invention] According to the method of the present invention, the corresponding glycosyl compound can be obtained from the halogenated sugar derivative and the alcohol under high pressure conditions. The method of the present invention is a safe and economical method as compared with the conventional method in that the operation is simple and it is not necessary to use any heavy metal salt such as silver or mercury. Further, as shown in Examples described later, according to the method of the present invention, α-O
-Glycoside bonds can be obtained with high selectivity.
[実施例] 次に本発明を実施例に基づき、さらに詳細に説明する。EXAMPLES Next, the present invention will be described in more detail based on examples.
実施例1 O−(2,3,4,6−テトラ−O−ベンジル−D−グ
ルコピラノシル)コレステロール(1) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(181.3mg,0.301mmo
l)、コレステロール(96.7mg,0.251mmo
l)、2,6−ルチジン(35μ,0.300mmol)
及びモレキュラシーブ4A(約100mg)を測りとり、
これに塩化メチレン(2m)を加えて溶かし、テフロ
ン製のカプセルに封じ込み、高圧反応容器にセットし
た。カプセルに約8000気圧の圧力をかけ、室温で2
0時間反応させた。圧力を常圧にもどし、不溶物をセラ
イトで濾過し、減圧下溶媒を留去した。得られた粗生成
物をシリカゲルカラムクロマトグラフィー(シリカ10
g、5→10%酢酸エチル−ヘキサン)に供し、αとβ
の混合物(1) (151.7mg,67%)を得た。Example 1 O- (2,3,4,6-tetra-O-benzyl-D-glucopyranosyl) cholesterol (1) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl Bromide (181.3mg, 0.301mmo
l), cholesterol (96.7mg, 0.251mmo
l), 2,6-lutidine (35 μ, 0.300 mmol)
And molecular sieve 4A (about 100 mg),
Methylene chloride (2 m) was added to and dissolved therein, and the mixture was sealed in a Teflon capsule and set in a high-pressure reaction vessel. Apply a pressure of about 8000 atm to the capsules, and
The reaction was allowed for 0 hours. The pressure was returned to normal pressure, the insoluble material was filtered through Celite, and the solvent was evaporated under reduced pressure. The obtained crude product was subjected to silica gel column chromatography (silica 10
g, 5 → 10% ethyl acetate-hexane), and α and β
To obtain a mixture (1) (151.7 mg, 67%).
HPLC(8%酢酸エチル−ヘキサン、流速1m/mi
n) tr(trは液クロのリテンションタイムを示す) α:10.4min,β:7.9min α/β=93/7 さらに分取薄層クロマトグラフィーによりα体を分取
し、エタノールら再結晶した。HPLC (8% ethyl acetate-hexane, flow rate 1 m / mi
n) tr (tr indicates the retention time of liquid chromatography) α: 10.4 min, β: 7.9 min α / β = 93/7 Further, the α-form was separated by preparative thin-layer chromatography and re-extracted from ethanol. It crystallized.
mp 145−145.5℃ (式中、Bnはベンジル基を表わす。) 実施例2 シクロハキシル 2,3,4,6−テトラ−O−ベンジ
ル−D−グルコピラノシド(2) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(179.2mg,0.297mmo
l)、シクロヘキサノール(24.9mg,0.246mmo
l)、2,6−ルチジン(35μ,0.300mmol)
及びモレキュラシーブ4A(約100mg)を測りとり、
これに塩化メチレン(2m)を加えて溶かし、テフロ
ン製のカプセルに封じ込み、高圧反応容器にセットし
た。カプセルに約8000気圧の圧力をかけ、室温で2
0時間反応させた。圧力を常圧に戻し、不溶物をセライ
トで濾過し、クロロホルムで希釈後、0.5M塩酸水溶
液で洗浄した。無水硫酸マグネシウムで乾燥後、減圧下
溶媒を留去し、得られた粗生成物をシリカゲルカラムク
ロマトグラフィー(シリカ15g、1:5→1:4 酢
酸エチル−ヘキサン)に供し、αとβの混合物(2) (122.7mg,79%)を得た。mp 145-145.5 ° C (In the formula, Bn represents a benzyl group.) Example 2 Cyclohaxyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (2) 2,3,4,6-tetra-O-benzyl- α-D-glucopyranosyl bromide (179.2 mg, 0.297 mmo
l), cyclohexanol (24.9mg, 0.246mmo
l), 2,6-lutidine (35 μ, 0.300 mmol)
And molecular sieve 4A (about 100 mg),
Methylene chloride (2 m) was added to and dissolved therein, and the mixture was sealed in a Teflon capsule and set in a high-pressure reaction vessel. Apply a pressure of about 8000 atm to the capsules, and
The reaction was allowed for 0 hours. The pressure was returned to normal pressure, the insoluble material was filtered through Celite, diluted with chloroform, and washed with a 0.5 M aqueous hydrochloric acid solution. After drying over anhydrous magnesium sulfate, the solvent was evaporated under reduced pressure, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 1: 5 → 1: 4 ethyl acetate-hexane) to give a mixture of α and β. (2) (122.7 mg, 79%) was obtained.
HPLC(10%酢酸エチル−ヘキサン、流速1m/
min) tr α:10.6min,β:9.0min α/β=92/8 (式中、Bnはベンジル基を表わす。) 実施例3 tert−ブチル 2,3,4,6−テトラ−O−ベン
ジル−D−グルコピラノシド(3) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(203.1mg,0.337mmo
l)、tert−ブチルアルコール(20.6mg,0.
278mmol)、2,6−ルチジン(39μ,0.33
5mmol)及びモレキュラシーブ4A(約100mg)を塩
化メチレン(2m)に溶かし、テフロン製のカプセル
に封じ、8000気圧の圧力をかけ、室温で20時間反
応させた。実施例2と同様の後処理を行ない、得られた
粗生成物をシリカゲルカラムクロマトグラフィー(シリ
カ15g,1:5→1:4 酢酸エチル−ヘキサン)に
供し、αとβの混合物(3) (98.5mg,59%)を得た。HPLC (10% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.6 min, β: 9.0 min α / β = 92/8 (In the formula, Bn represents a benzyl group.) Example 3 tert-butyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (3) 2,3,4,6-tetra-O- Benzyl-α-D-glucopyranosyl bromide (203.1 mg, 0.337 mmo
l), tert-butyl alcohol (20.6 mg, 0.
278 mmol), 2,6-lutidine (39 μ, 0.33
(5 mmol) and molecular sieve 4A (about 100 mg) were dissolved in methylene chloride (2 m), the mixture was sealed in a Teflon capsule, and a pressure of 8000 atm was applied, and the reaction was carried out at room temperature for 20 hours. The same post-treatment as in Example 2 was performed, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 1: 5 → 1: 4 ethyl acetate-hexane) to give a mixture of α and β (3) ( 98.5 mg, 59%) was obtained.
HPLC(10%酢酸エチル−ヘキサン,流速1m/
min) tr α:10.9min,β:9.9min α/β=93/7 (式中、Bnはベンジル基を表わす。) 実施例4 メチル 2,3,4,−トリ−O−ベンジル−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−α−D−グルコピラノシド(4) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(232.2mg,0.385mmo
l)、メチル 2,3,4−トリ−O−ベンジル−α−
D−グルコピラノシド (117.6mg,0.253mmol)、ジイソプロピルエ
チルアミン(70μ,0.402mmol)及びモレキュ
ラシーブ4A(約100mg)を塩化メチレン(2m)
に溶かし、テフロン製のカプセルに封じ、40℃、80
00気圧で20時間反応させた。実施例2と同様の後処
理を行ない、得られた粗生成物をシリカゲルカラムクロ
マトグラフィー(シリカ10g,10→20% 酢酸エ
チル−ヘキサン)に供し、αとβの混合物(4) (171.8mg,69%)を得た。HPLC (10% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.9 min, β: 9.9 min α / β = 93/7 (In the formula, Bn represents a benzyl group.) Example 4 Methyl 2,3,4, -tri-O-benzyl-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -α-D-glucopyranoside (4) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl Bromide (232.2mg, 0.385mmo
l), methyl 2,3,4-tri-O-benzyl-α-
D-glucopyranoside (117.6 mg, 0.253 mmol), diisopropylethylamine (70 μ, 0.402 mmol) and molecular sieve 4A (about 100 mg) were added to methylene chloride (2 m).
Dissolve in, seal in a Teflon capsule, 40 ℃, 80
The reaction was carried out at 00 atm for 20 hours. The same post-treatment as in Example 2 was performed, and the resulting crude product was subjected to silica gel column chromatography (silica 10 g, 10 → 20% ethyl acetate-hexane) to give a mixture of α and β (4) (171.8 mg). , 69%).
HPLC(ヘキサン/THF=5/1,流速1m/mi
n) tr α:15.7min,β:13.9min α/β=85/15 (式中、Bnはベンジル基を表わす。) 実施例5 1,2,3,4−ジ−O−イソプロピリデン−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−α−D−カラクトピラノシド(5) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(185.0mg,0.307mmo
l)、1,2,3,4−ジ−O−イソプロピリデン−α
−D−ガラクトピラノース(65.7mg,0.252mm
ol)、ジイソプロピルエチルアミン(53μ,0.3
04mmol)及びモレキュラシーブ4A(約100mg)を
塩化メチレン(2m)に溶かし、テフロン製のカプセ
ルに封じ、25℃、約8000気圧で44時間反応させ
た。実施例2と同様の後処理をし、得られた粗生成物を
シリカゲルカラムクロマトグラフィー(シリカ10g、
10→20% 酢酸エチル−ヘキサン)に供し、αとβ
の混合物(5) (156.0mg,79%)を得た。HPLC (hexane / THF = 5/1, flow rate 1 m / mi
n) tr α: 15.7 min, β: 13.9 min α / β = 85/15 (In the formula, Bn represents a benzyl group.) Example 5 1,2,3,4-di-O-isopropylidene-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -α-D-galactopyranoside (5) 2,3,4,6-tetra-O-benzyl-α-D-gluco Pyranosyl bromide (185.0 mg, 0.307 mmo
l), 1,2,3,4-di-O-isopropylidene-α
-D-galactopyranose (65.7 mg, 0.252 mm)
ol), diisopropylethylamine (53μ, 0.3
(04 mmol) and molecular sieves 4A (about 100 mg) were dissolved in methylene chloride (2 m), encapsulated in a Teflon capsule, and reacted at 25 ° C. and about 8000 atm for 44 hours. The same post-treatment as in Example 2 was carried out, and the resulting crude product was subjected to silica gel column chromatography (silica 10 g,
10 → 20% ethyl acetate-hexane) to obtain α and β
To give a mixture (5) of (156.0 mg, 79%).
HPLC(20%酢酸エチル−ヘキサン,流速1m/
min) tr α:10.2min,β:11.6min α/β=88/12 (式中、Bnはベンジル基を表わす。) 実施例6 1,2,3,4−テトラ−O−アセチル−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−β−D−グルコピラノース(6) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(182.5mg,0.303mmo
l)、1,2,3,4−テトラ−O−アセチル−β−D
−グルコピラノース(87.0mg,0.250mmol)、
2,6−ルチジン(35μ,0.300mmol)及びモ
レキュラシーブ4A(約100mg)を塩化メチレン(2
m)に溶かし、テフロン製のカプセルに封じ、25
℃、約8000気圧で20時間反応させた。実施例2と
同様の後処理をし、得られた粗成生物をシリカゲルカラ
ムクロマトグラフィー(シリカ20g、30→35%
酢酸エチル−ヘキサン)に供し、αとβの混合物(6)
(104.8mg,48%)を得た。HPLC (20% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.2 min, β: 11.6 min α / β = 88/12 (In the formula, Bn represents a benzyl group.) Example 6 1,2,3,4-tetra-O-acetyl-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -β-D-glucopyranose (6) 2,3,4,6-tetra-O-benzyl-α-D-glucopyrano Silbromide (182.5mg, 0.303mmo
l), 1,2,3,4-tetra-O-acetyl-β-D
-Glucopyranose (87.0 mg, 0.250 mmol),
2,6-lutidine (35 μ, 0.300 mmol) and molecular sieve 4A (about 100 mg) were added to methylene chloride (2
m), seal in Teflon capsules, 25
The reaction was carried out at a temperature of about 8000 atm for 20 hours. The same post-treatment as in Example 2 was carried out, and the resulting crude product was subjected to silica gel column chromatography (silica 20 g, 30 → 35%.
Ethyl acetate-hexane), and a mixture of α and β (6)
(104.8 mg, 48%) was obtained.
HPLC(3%エタノール−ヘキサン,流速1m/mi
n) tr α:10.7min,β:9.8min α/β=94/6 (式中、Bnはベンジル基、Acはアセチル基を表わ
す。) 実施例7 N−ベンジルオキシカルボニル−O−(2,3,4,6
−テトラ−O−ベンジル−α−D−グルコピラノシル)
−L−セリン メチルエステル(7) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(189.3mg,0.314mmo
l)、N−ベンジルオキシカルボニル−L−セリン メ
チルエステル(65.3mg,0.258mmol)、2,6
−ルチジン(36μ,0.309mmol)及びモレキュ
ラシーブ4A(約100mg)を塩化メチレン(2m)
に溶かし、テフロン製のカプセルに封じ込み、25℃、
約8000気圧で20時間反応させた。実施例2と同様
の後処理を行ない、得られた粗成生物をシリカゲルカラ
ムクロマトグラフィー(シリカ15g、5→10% エ
ーテル−ベンゼン)に供し、αとβの混合物(7)(1
19.2mg,60%)を得た。HPLC (3% ethanol-hexane, flow rate 1 m / mi
n) tr α: 10.7 min, β: 9.8 min α / β = 94/6 (In the formula, Bn represents a benzyl group and Ac represents an acetyl group.) Example 7 N-benzyloxycarbonyl-O- (2,3,4,6)
-Tetra-O-benzyl-α-D-glucopyranosyl)
-L-serine methyl ester (7) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl bromide (189.3 mg, 0.314 mmo
l), N-benzyloxycarbonyl-L-serine methyl ester (65.3 mg, 0.258 mmol), 2,6
-Lutidine (36μ, 0.309mmol) and molecular sieve 4A (about 100mg) in methylene chloride (2m).
Dissolve in, seal in a Teflon capsule, 25 ℃,
The reaction was carried out at about 8000 atm for 20 hours. The same post-treatment as in Example 2 was performed, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 5 → 10% ether-benzene) to give a mixture of α and β (7) (1).
19.2 mg, 60%) was obtained.
HPLC(アセトニトリル/水=5/1,流速1m/
min) tr α:10.1min,β:11.5min α/β=95/5 (式中、Bnはベンジル基を表わす。)HPLC (acetonitrile / water = 5/1, flow rate 1 m /
min) tr α: 10.1 min, β: 11.5 min α / β = 95/5 (In the formula, Bn represents a benzyl group.)
Claims (1)
下、アルコール類と高圧条件下(4000気圧以上)反
応させることを特徴とするグリコシル化法。1. A glycosylation method, which comprises reacting a halogenated sugar derivative with an alcohol in the presence of a tertiary amine under high pressure conditions (at least 4000 atm).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2062066A JPH0635467B2 (en) | 1990-03-13 | 1990-03-13 | Novel glycosylation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2062066A JPH0635467B2 (en) | 1990-03-13 | 1990-03-13 | Novel glycosylation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03264595A JPH03264595A (en) | 1991-11-25 |
| JPH0635467B2 true JPH0635467B2 (en) | 1994-05-11 |
Family
ID=13189362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2062066A Expired - Lifetime JPH0635467B2 (en) | 1990-03-13 | 1990-03-13 | Novel glycosylation method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0635467B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0647233A1 (en) * | 1992-06-26 | 1995-04-12 | Pfizer Inc. | Steroidal beta-o-cellobioside heptaalkanoate process |
| CN103864860B (en) * | 2014-03-17 | 2016-08-31 | 柯中炉 | A kind of trehalose derivative and its preparation method and application |
| JP6467762B2 (en) * | 2017-02-10 | 2019-02-13 | 香港友池有限公司 | Method for producing glycosylated stilbenoid compound |
| WO2018147306A1 (en) * | 2017-02-10 | 2018-08-16 | マイスターバイオ株式会社 | Method for producing glycosylated stilbenoid compound |
-
1990
- 1990-03-13 JP JP2062066A patent/JPH0635467B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03264595A (en) | 1991-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3231765B2 (en) | Method for producing demethyl epipodophyllotoxin | |
| JP2001527568A (en) | Novel glycosylated derivative of gingolide, its use as medicament and pharmaceutical composition containing it | |
| JPH0635467B2 (en) | Novel glycosylation method | |
| JP3816570B2 (en) | Acylating agent | |
| JP2540400B2 (en) | Method for producing L-talopyranoside derivative | |
| US8524873B2 (en) | Sugar donor | |
| Dumont-Hornebeck et al. | Synthesis of di-and trisaccharides incorporating a crown ether macrocycle | |
| JPH0742304B2 (en) | Novel anthracycline derivative and method for producing the same | |
| US5344924A (en) | Solvent-free synthesis of ethereally substituted blocked monosaccharides and the selective hydrolysis thereof | |
| AU641644B2 (en) | A process for the preparation of etoposides | |
| AU601552B2 (en) | N-acetyl-3-fluoro-neuraminic acid derivatives and preparation thereof | |
| US6075132A (en) | Ursodeoxycholic acid derivatives and methods for producing them | |
| Wessel et al. | Selectively Deoxygenated Derivatives of β-Maltosyl-(1→ 4)-Trehalose as Biological Probes | |
| TAKIURA et al. | Studies of Oligosaccharides. X. Synthesis of Isomaltose and Isomaltotriose by Benzyl Blocking Method | |
| Rosenthal et al. | 9-[3-acetamido-3-C-(carboxymethyl)-3-deoxy-32, 2-lactone-α (andβ)-D-xylofuranosyl] adenine-analogs of the nucleoside moiety of the polyoxins | |
| CN111269279B (en) | A kind of method for preparing halogenated sugar under mild conditions | |
| JPH11279192A (en) | Production of new chromanol glycoside | |
| JP3265425B2 (en) | Phosphorylated trisaccharide serine, sulfated / phosphorylated trisaccharide serine, and methods for their synthesis | |
| HU207337B (en) | Process for producing tetrasaccharides | |
| JPH09241288A (en) | Stereoselective method for producing glycosyl compound | |
| HUT62305A (en) | Process for producing sugar epitops | |
| JPH02295996A (en) | Preparation of glucosaminyl-epi-podophyllotoxin derivative | |
| EP0582153B1 (en) | Method of preparing 4-deoxy-D-mannose | |
| JP3542143B2 (en) | Method for producing oligosaccharide | |
| JP2694282B2 (en) | Glycosylation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |